{"id":332780,"date":"2026-10-29T17:56:32","date_gmt":"2026-10-29T12:26:32","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/par-drugs-and-chemicals-q2-results-fy27-pat-3-crore\/"},"modified":"2026-10-29T17:56:32","modified_gmt":"2026-10-29T12:26:32","slug":"par-drugs-and-chemicals-q2-results-fy27-pat-3-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/par-drugs-and-chemicals-q2-results-fy27-pat-3-crore\/","title":{"rendered":"Par Drugs And Chemicals Q2 Results FY27: PAT Falls 36.32% to Rs 2.63 Cr, Revenue Rs 27.43 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Par Drugs And Chemicals Q2 Results FY27 were declared on 29 October 2026 on a Standalone basis. These quarterly results show revenue of Rs 27.43 Cr, down 4.29% YoY from Rs 28.66 Cr. Net profit was Rs 2.63 Cr against Rs 4.13 Cr a year earlier, a 36.32% fall, and Operating Profit was Rs 4.5 Cr, down 25.86%. YoY growth is therefore negative on all three lines.<\/p>\n<\/div>\n

Par Drugs And Chemicals Ltd<\/a> (PAR) Q2 Results FY27 announced on 29 October 2026, covering the company’s financial performance for the July to September quarter. The results date brought standalone results with revenue of Rs 27.43 Cr and PAT of Rs 2.63 Cr. In this filing, Par Drugs And Chemicals Q2 Results FY27 are compared with the same quarter of last year on a Standalone basis.<\/p>\n

This results analysis of Par Drugs And Chemicals Q2 Results walks through the financial highlights, the business drivers disclosed for the company, the FY27 outlook and the risks to watch. Everything below is drawn from the filing figures, so the section that follows sets out the numbers side by side.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n